Abby Li

1.5k total citations
47 papers, 747 citations indexed

About

Abby Li is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Abby Li has authored 47 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Abby Li's work include Respiratory viral infections research (24 papers), Neonatal Respiratory Health Research (19 papers) and Congenital Diaphragmatic Hernia Studies (13 papers). Abby Li is often cited by papers focused on Respiratory viral infections research (24 papers), Neonatal Respiratory Health Research (19 papers) and Congenital Diaphragmatic Hernia Studies (13 papers). Abby Li collaborates with scholars based in Canada, United States and Sweden. Abby Li's co-authors include Krista L. Lanctôt, Bosco Paes, Ian Mitchell, Nathan Herrmann, Daniel Y. Kwok, Rebecca Wu, C.N. Catherine Lam, A. W. Neumann, Shankar Tumati and Sandra E. Black and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Abby Li

46 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abby Li Canada 18 377 273 156 123 94 47 747
Mohammed Al‐Beltagi Egypt 19 181 0.5× 118 0.4× 116 0.7× 152 1.2× 19 0.2× 90 1000
Jean‐Michel Hascoët France 22 255 0.7× 724 2.7× 262 1.7× 67 0.5× 44 0.5× 92 1.4k
Riccardo De Giorgi Italy 16 195 0.5× 79 0.3× 240 1.5× 141 1.1× 127 1.4× 59 949
Helen Mactier United Kingdom 22 347 0.9× 339 1.2× 113 0.7× 36 0.3× 27 0.3× 74 1.8k
Dawei Liu China 11 131 0.3× 68 0.2× 178 1.1× 181 1.5× 20 0.2× 30 625
Rogier C.J. de Jonge Netherlands 14 164 0.4× 281 1.0× 172 1.1× 54 0.4× 38 0.4× 50 853
Wanli Xu United States 18 172 0.5× 149 0.5× 51 0.3× 83 0.7× 32 0.3× 62 1.2k
Ira Adams‐Chapman United States 24 326 0.9× 1.1k 3.9× 195 1.3× 127 1.0× 19 0.2× 37 2.1k
Kazushi Nomura Japan 15 72 0.2× 50 0.2× 40 0.3× 142 1.2× 43 0.5× 51 861
Andrea Cutting United States 9 311 0.8× 161 0.6× 31 0.2× 41 0.3× 69 0.7× 14 795

Countries citing papers authored by Abby Li

Since Specialization
Citations

This map shows the geographic impact of Abby Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Li more than expected).

Fields of papers citing papers by Abby Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abby Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Li. The network helps show where Abby Li may publish in the future.

Co-authorship network of co-authors of Abby Li

This figure shows the co-authorship network connecting the top 25 collaborators of Abby Li. A scholar is included among the top collaborators of Abby Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abby Li. Abby Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Darrell H. S., Abby Li, Adrienne K. Chan, et al.. (2025). Monkeypox Virus Transcriptional Profiles and Host Responses in Skin Lesion Swabs Among Individuals With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 232(5). e849–e858. 1 indexed citations
2.
Li, Abby, Mary Hummel, Adrienne K. Chan, et al.. (2025). Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada. The Journal of Infectious Diseases. 233(1). e132–e139. 1 indexed citations
3.
Lanctôt, Krista L., Clara Chen, Alex Kiss, et al.. (2023). Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). International Psychogeriatrics. 35(11). 664–672. 1 indexed citations
4.
Tumati, Shankar, et al.. (2021). Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects. Neurochemistry International. 152. 105250–105250. 12 indexed citations
5.
Tumati, Shankar, et al.. (2021). Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects. Drugs & Aging. 39(2). 153–163. 39 indexed citations
6.
Sinyor, Mark, Krista L. Lanctôt, Mahwesh Saleem, et al.. (2020). Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review. Journal of Affective Disorders. 267. 185–190. 18 indexed citations
7.
Paes, Bosco, et al.. (2020). Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children. The Pediatric Infectious Disease Journal. 39(6). 539–545. 7 indexed citations
8.
Bjornson, Candice, et al.. (2018). Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?. European Journal of Clinical Microbiology & Infectious Diseases. 37(6). 1113–1118. 9 indexed citations
9.
Li, Abby, et al.. (2017). First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015). European Journal of Pediatrics. 176(3). 413–422. 10 indexed citations
10.
Hui, Charles, Bosco Paes, Jesse Papenburg, et al.. (2016). Palivizumab Adherence and Outcomes in Canadian Aboriginal Children. The Pediatric Infectious Disease Journal. 35(11). 1187–1193. 2 indexed citations
11.
Manzoni, Paolo, Bosco Paes, Krista L. Lanctôt, et al.. (2016). Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy. The Pediatric Infectious Disease Journal. 36(1). 2–8. 23 indexed citations
12.
Li, Abby, et al.. (2016). Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015). The Pediatric Infectious Disease Journal. 36(5). 445–450. 16 indexed citations
13.
Paes, Bosco, et al.. (2015). Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention. PLoS ONE. 10(8). e0134711–e0134711. 18 indexed citations
14.
15.
Paes, Bosco, et al.. (2013). Hospitalization for Respiratory Syncytial Virus Illness in Down Syndrome Following Prophylaxis With Palivizumab. The Pediatric Infectious Disease Journal. 33(2). e29–e33. 24 indexed citations
16.
Lanctôt, Krista L., et al.. (2013). Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease. Canadian Geriatrics Journal. 16(4). 180–185. 14 indexed citations
17.
Bal‐Price, Anna, Sandra Coecke, Lucio G. Costa, et al.. (2012). Conference Report: Advancing the Science of Developmental Neurotoxicity (DNT): Testing for Better Safety Evaluation.. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 5 indexed citations
18.
Lanctôt, Krista L., et al.. (2012). Does Pharmacological Treatment of Neuropsychiatric Symptoms in Alzheimerʼs Disease Relieve Caregiver Burden?. Drugs & Aging. 29(3). 167–179. 30 indexed citations
19.
Li, Abby, et al.. (2012). A review of cost–effectiveness of palivizumab for respiratory syncytial virus. Expert Review of Pharmacoeconomics & Outcomes Research. 12(5). 553–567. 21 indexed citations
20.
Paes, Bosco, Ian Mitchell, Abby Li, & Krista L. Lanctôt. (2011). Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations. European Journal of Pediatrics. 171(5). 833–841. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammed Al‐Beltagi Breakdown of academic impact, for papers by Jean‐Michel Hascoët Breakdown of academic impact, for papers by Riccardo De Giorgi Breakdown of academic impact, for papers by Helen Mactier Breakdown of academic impact, for papers by Dawei Liu Breakdown of academic impact, for papers by Rogier C.J. de Jonge Breakdown of academic impact, for papers by Wanli Xu Breakdown of academic impact, for papers by Ira Adams‐Chapman Breakdown of academic impact, for papers by Kazushi Nomura Breakdown of academic impact, for papers by Andrea Cutting
Rankless by CCL
2026